NY-ALVAREZ-&-MARSAL
18.1.2023 07:01:35 CET | Business Wire | Press release
Leading global professional services firm Alvarez & Marsal (A&M) has announced the promotion of 85 professionals across Brazil, Benelux, Canada, Cayman Islands, China, France, Germany, India, Spain, United Arab Emirates, United Kingdom and the United States, to the position of Managing Director.
Tony Alvarez II and Bryan Marsal, A&M’s Co-Founders, stated, “Congratulations to all our newly promoted Managing Directors. Their commitment to help clients maximize value and drive change amid ongoing macro-economic challenges builds upon our legacy of operational excellence while advancing our results-oriented mission. Their proven ability to help solve for clients’ complex problems is critical to the firm’s success and growth moving forward.”
Henry Chambers, Hong Kong
Eden Chen, Shanghai
Sally Sun, Hong Kong
Pedro Bortolotto, São Paulo
Marcelo Compte, São Paulo
Rodrigo Domingues, São Paulo
Lilian Giorgi, São Paulo
Rodrigo Hong, São Paulo
Henrique Kanashiro, São Paulo
Rafael Mendonca Rodrigues, São Paulo
Fabio Missiato, São Paulo
Corporate Performance Improvement
Tiffany Guthrie, Houston
Mike Hall, San Francisco
John McKinnis, Dallas
Sam Rudkin, Atlanta
Kenneth Cochran, Charlotte
Jeffrey Dwyer, Chicago
Lakshman Lakshmanan, Dallas
Chad Lusk, Chicago
Joanna Rangarajan, New York
Global Disputes and Investigations
Lee Betteridge, London
Gary Foster, London
EMEA – Performance Improvement
Private Equity Performance Improvement
Nicola Barbini, London
Chris Gobby, London
Britta Mittler, Frankfurt
Till Prinz, Dusseldorf
Tim Veen, Munich
Gerardo Villalba Bello, Madrid
Ysabel Gaspar Zayco, London
Robert Bradbury, London
Dominic Roope, London
Jatin Arora, Dubai
Mark Bennett, Paris
Daran Hopper, London
Dirk Naujokat, Munich
Steve Trainor, London
Diana Wong, London
EMEA Restructuring
Barry Lynch, Grand Cayman
Helen Skeates, London
David Johnston, London
José Miguel Gómez Rivas, Madrid
Bill Ozturk, Dubai
Environmental, Social and Governance (ESG)
Stephanie Weiler, Chicago
JoyAnn Book, Phoenix
Bianca A. Briola Charlotte
David Nidetz, Detroit
Rich Rieger, Chicago
Anup Gandhi, Mumbai
Pranav Sheth, Mumbai
Infrastructure & Capital Projects
Sue Frost, Washington, D.C.
Alan Richard, Washington, D.C.
Private Equity Performance Group
Kent Edgerton, Nashville
Jana Gold, Washington, D.C.
Brad Howard, New York
Larry Thomas, Tampa
Klaus Weisenberger, San Francisco
Daniel Harlan, Washington, D.C
Restructuring & Turnaround (North America)
Taylor Atwood, Dallas
Matthew Davidson, Detroit
Chad Ellison, Calgary
Kamila Khairoullina, New York
Mark Sidorenkov, Phoenix
Jeff Sielinski, Detroit
Michael Zembillas, Atlanta
Simon Bernstein, New York
Stephanie Doughty, Houston
Michael Farkas, New York
Simon Gore, London
Jack Hollyman, London
Jac Emilio Martinez, Miami
Joseph Plati, New York
Brendan Sinnott, New York
Katya Umanskaya, Los Angeles
Global Transaction Advisory Group
Anuj Astir, New York
Nout Brugman, Amsterdam
David Cho, Chicago
Vitor Garcia, Sao Paulo
Jimmy Glenn, Atlanta
Nick Lynch, London
Jai Tandan, Mumbai
Rhett Taylor, Nashville
Nick Thoele, New York
Cedric Zana, Paris
Cole Corbin, New York
Steven Fischoff, Chicago
About Alvarez & Marsal
Companies, investors and government entities around the world turn to Alvarez & Marsal (A&M) for leadership, action and results. Privately held since its founding in 1983, A&M is a leading global professional services firm that provides advisory, business performance improvement and turnaround management services. When conventional approaches are not enough to create transformation and drive change, clients seek our deep expertise and ability to deliver practical solutions to their unique problems.
With over 7,000 people across five continents, we deliver tangible results for corporates, boards, private equity firms, law firms and government agencies facing complex challenges. Our senior leaders, and their teams, leverage A&M’s restructuring heritage to help companies act decisively, catapult growth and accelerate results. We are experienced operators, world-class consultants, former regulators and industry authorities with a shared commitment to telling clients what’s really needed for turning change into a strategic business asset, managing risk and unlocking value at every stage of growth.
To learn more, visit: AlvarezandMarsal.com. Follow A&M on LinkedIn, Twitter, and Facebook.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230117005828/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom